iBio, Inc. (IBIO)
1.42
-0.01
(-0.70%)
USD |
NASDAQ |
Aug 24, 16:00
1.40
-0.02
(-1.41%)
After-Hours: 20:00
iBio Market Cap : 49.05M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 49.05M |
| August 21, 2026 | 49.40M |
| August 20, 2026 | 50.78M |
| August 19, 2026 | 51.47M |
| August 18, 2026 | 50.09M |
| August 17, 2026 | 50.09M |
| August 14, 2026 | 49.40M |
| August 13, 2026 | 48.36M |
| August 12, 2026 | 50.78M |
| August 11, 2026 | 50.78M |
| August 10, 2026 | 48.36M |
| August 07, 2026 | 48.71M |
| August 06, 2026 | 48.02M |
| August 05, 2026 | 48.36M |
| August 04, 2026 | 50.43M |
| August 03, 2026 | 49.05M |
| July 31, 2026 | 48.36M |
| July 30, 2026 | 48.02M |
| July 29, 2026 | 46.98M |
| July 28, 2026 | 48.02M |
| July 27, 2026 | 50.09M |
| July 24, 2026 | 49.40M |
| July 23, 2026 | 48.36M |
| July 22, 2026 | 47.67M |
| July 21, 2026 | 48.71M |
| Date | Value |
|---|---|
| July 20, 2026 | 47.32M |
| July 17, 2026 | 47.67M |
| July 16, 2026 | 46.63M |
| July 15, 2026 | 49.40M |
| July 14, 2026 | 49.74M |
| July 13, 2026 | 50.09M |
| July 10, 2026 | 52.16M |
| July 09, 2026 | 52.16M |
| July 08, 2026 | 52.51M |
| July 07, 2026 | 54.92M |
| July 06, 2026 | 55.96M |
| July 02, 2026 | 58.03M |
| July 01, 2026 | 60.45M |
| June 30, 2026 | 60.45M |
| June 29, 2026 | 59.76M |
| June 26, 2026 | 57.69M |
| June 25, 2026 | 54.92M |
| June 24, 2026 | 55.96M |
| June 23, 2026 | 57.00M |
| June 22, 2026 | 60.11M |
| June 18, 2026 | 58.38M |
| June 17, 2026 | 55.27M |
| June 16, 2026 | 53.54M |
| June 15, 2026 | 57.00M |
| June 12, 2026 | 58.38M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Capricor Therapeutics, Inc. | 395.14M |
| Ocugen, Inc. | 461.10M |
| CytomX Therapeutics, Inc. | 716.89M |
| ACADIA Pharmaceuticals, Inc. | 5.104B |
| Alnylam Pharmaceuticals, Inc. | 31.56B |
Market Cap Related Metrics
| PS Ratio | 340.96 |
| Price to Book Value | 0.6326 |
| Price | 1.42 |
| Earnings Yield | -40.68% |